Microtubules, the dynamic filaments that form the cell's internal scaffolding, have long been viewed as mere passive ...

GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and the brain later in life, investigators at Johns Hopkins Medicine and ...

Though TB remains the world's top infectious disease killer, there's cause for hope, Fred Hutch Cancer Center experts say.

A male in his 50s presented with profound leucocytosis, systemic symptoms and marked hepatosplenomegaly. Initial workup with peripheral blood flow cytometry suggested T-cell prolymphocytic leukaemia ...

The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...

For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen.

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...